Pneumococcal vaccination in adults: Recommendations, trends, and prospects

Paul V. Targonski, Gregory A. Poland

Research output: Contribution to journalReview article

23 Scopus citations

Abstract

The Us Centers for Disease Control and Prevention recommends vaccination against Streptococcus pneumoniae for all people age 65 and older and also for younger people at high risk. However, experts continue to debate the efficacy of the vaccine; most observational studies found it beneficial, while clinical trials were inconclusive as a group. Although pneumococcal vaccination may or may not protect against pneumonia or death from any cause, it does significantly decrease the risk of invasive pneumococcal disease and is worthwhile for this reason.

Original languageEnglish (US)
Pages (from-to)401-414
Number of pages14
JournalCleveland Clinic journal of medicine
Volume74
Issue number6
DOIs
StatePublished - Jun 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Pneumococcal vaccination in adults: Recommendations, trends, and prospects'. Together they form a unique fingerprint.

  • Cite this